| 注册
首页|期刊导航|中医临床研究|基于"清、消、补"理论探讨参芪泄浊饮联合海昆肾喜胶囊治疗慢性肾脏病的临床疗效研究

基于"清、消、补"理论探讨参芪泄浊饮联合海昆肾喜胶囊治疗慢性肾脏病的临床疗效研究

孙琬淳 郭玲 何学红 朱昱霖 曹书瑞

中医临床研究2025,Vol.17Issue(27):43-50,8.
中医临床研究2025,Vol.17Issue(27):43-50,8.DOI:10.3969/j.issn.1674-7860.2025.27.008

基于"清、消、补"理论探讨参芪泄浊饮联合海昆肾喜胶囊治疗慢性肾脏病的临床疗效研究

A study on the clinical effect of Shenqi Xiezhuo Yin plus the Haikun Shenxi capsules on chronic kidney disease based on the theory of"clearing,eliminating,and tonifying"

孙琬淳 1郭玲 2何学红 2朱昱霖 1曹书瑞1

作者信息

  • 1. 辽宁中医药大学,辽宁 沈阳,112300
  • 2. 辽宁中医药大学附属医院,辽宁 沈阳,112300
  • 折叠

摘要

Abstract

Objective:To evaluate the clinical effect of Shenqi Xiezhuo Yin(参芪泄浊饮)plus the Haikun Shenxi capsules(海昆肾喜胶囊)on stage 2 to 5 chronic kidney disease in patients with spleen-kidney Qi(气)deficiency complicated by dampness-turbidity and blood stasis syndrome,providing a theoretical basis for clinical practice.Methods:Patients diagnosed with stages 2 to 5 chronic kidney disease by Western medicine and with spleen-kidney Qi deficiency complicated by dampness-turbidity and blood stasis syndrome according to TCM syndrome differentiation who were admitted to the Nephrology Department of the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from September 2023 to September 2024 were selected,among whom 120 cases were screened out as the research subjects according to the inclusion and exclusion criteria.According to the treatment plan,the included patients were divided into Group A(took the Haikun Shenxi capsules,31 cases),Group B(took Shenqi Xiezhuo Yin,39 cases),and Group C(took combined therapy,50 cases).Clinical parameters including serum creatinine,blood urea nitrogen,glomerular filtration rate(eGFR),and TCM syndrome scores of the patients in the three groups were observed before and after treatment.Relevant statistical analysis was performed by the SPSS 26.0 to evaluate the therapeutic effect.Results:After 4 weeks of treatment,the renal function indicators were ameliorated across all groups.Moreover,the reduction of serum creatinine and the improvement degree of eGFR in Group C were significantly better than those in Group A and Group B(P<0.01).The total efficiency in Group C was significantly higher than Group B and Group A,and the differences were statistically significant(P<0.05).Conclusion:Shenqi Xiezhuo Yin plus the Haikun Shenxi capsules can effectively improve renal function and ameliorate TCM clinical syndromes of chronic kidney disease patients,and its therapeutic effect is superior to that of monotherapy regimens.

关键词

清、消、补/慢性肾脏病/参芪泄浊饮

Key words

Clearing,eliminating,tonifying/Chronic kidney disease/Shenqi Xiezhuo Yin

分类

医药卫生

引用本文复制引用

孙琬淳,郭玲,何学红,朱昱霖,曹书瑞..基于"清、消、补"理论探讨参芪泄浊饮联合海昆肾喜胶囊治疗慢性肾脏病的临床疗效研究[J].中医临床研究,2025,17(27):43-50,8.

基金项目

全国名老中医药专家传承工作室建设项目(国中医药人教函[2022]75号) (国中医药人教函[2022]75号)

辽宁省教育厅基本科研项目—面上项目—自然科学类(JYTMS20231819). (JYTMS20231819)

中医临床研究

1674-7860

访问量0
|
下载量0
段落导航相关论文